Semax FAQ: common questions answered
A Russian nasal peptide with limited human evidence for brain and nerve effects.
Also called: Семакс, ACTH(4–7)-PGP, MEHFPGP.
Nootropic peptides · ACTH-fragment analogue studied for brain and nerve effects.
- Is Semax FDA-approved? No. Semax free base: limited to intranasal forms. The October 30, 2026 Federal Register describes a nonbinding draft interim HHS 503A enforcement policy, with public comment invited. It is conditional on eligible state-licensed pharmacies, federal facilities or licensed physicians, a patient-specific prescription, a single active ingredient, specified identity and route, qualified manufacturing, lot testing, reporting and labeling conditions. It is not FDA drug approval, a final 503A listing or general authorization to supply research products.
- How do people take it? Nasal spray, two or three times in the first half of the day. 3–5 days. Source: clinician-published.
- What's the difference between Semax and Selank? Semax: a Russian nasal peptide with limited human evidence for brain and nerve effects. Selank: a Russian nasal anxiety peptide with uncertain long-term benefit and safety. Why people pair them: people combine them for focus with less perceived anxiety. No human trial tested the combination.
- Can I take it with Selank? People combine them for focus with less perceived anxiety. No human trial tested the combination. Combined effects, compatibility and long-term safety are unknown. Source: reported by users. Ask a doctor before combining anything.
- Is it banned in sport? It is unclear (WADA 2026). S0 requires no approval by any government. Russian registration prevents an automatic S0 conclusion; obtain a substance-specific ruling.
- How long does a mixed vial last? No validated after-mixing shelf life was found. A saline recipe does not establish stability, preservation or microbial quality.
Related to Semax
- Selank: A Russian nasal anxiety peptide with uncertain long-term benefit and safety.
- PE-22-28: An experimental mood peptide studied in mice, with no human trials found.
- Dihexa: An experimental memory compound with disputed animal research and no established human dose.
- P21: An experimental memory peptide with animal research and no established human dose or safety profile.
- Cerebrolysin: An injectable pig brain mixture with mixed stroke, brain-injury and dementia evidence.
Sources
- 503B Bulk Drug Substances List, FDA · FDA · 2026
- Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act, FDA · FDA · 2026
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks, FDA · FDA · 2026
- Federal Register: nonbinding draft HHS interim policy, October 30 2026, 2026
- HHS 503A peptide interim enforcement policy and conditions, October 30 2026, 2026
- July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee - 07/23/2026, FDA · FDA · 2026
- MHRA Products | Home, MHRA · MHRA · 2026
- The Prohibited List, World Anti-Doping Agency · World Anti-Doping Agency · 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026, Australian Government · Australian Government · 2026
- Think twice before injecting peptides bought online: unauthorized products can seriously harm you, Health Canada · Health Canada · 2026
- Anaphylaxis, NHS · NHS · 2023
- Australian Register of Therapeutic Goods (ARTG), Therapeutic Goods Administration · TGA
- Search, European Medicines Agency
- Semax-Related Bulk Drug Substances: Semax (Free Base) and Semax Acetate
- Symptoms of a stroke
Sources checked: 2026-10-18.
Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.